NEW YORK – 23andMe said late Friday that it received a letter from the Listing Qualifications Department of the Nasdaq that it would be delisted and that trading of the company's shares would be suspended, effective March 31.
In a briefing filed with the US Securities and Exchange Commission, the Sunnyvale, California-based company said that it would not appeal the decision.
The filing comes on the heels of this week's announcement that the US Bankruptcy Court for the Eastern District of Missouri cleared 23andMe to continue paying its employees and certain vendors while seeking Chapter 11 bankruptcy protections, and to sell its assets.
23andMe filed for bankruptcy earlier this week.